Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
BioHalo is transforming the halogenated chemicals industry by developing more sustainable and bio-based fluorinated polymers.
MedicQuant is a medical equipment manufacturing company developing diagnostic kits for blood anticoagulant properties.
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Upstream Foods is developing a novel fat ingredient to uplevel seafood alternatives
Heka VR is a virtual reality platform developing a novel therapy to aid people suffering from auditory hallucinations.
Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.
Sevenless Therapeutics focus on manufacturing of pharmaceuticals.
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.
Paragit Solutions develops systems for improving care and diagnosis of movement disorders.
Probmet is a precision oncology therapeutics company developing treatments for cancer.
Ampa Medical provides healthcare services for people living with an ostomy.
Pephexia Therapeutics is a biotechnology company working with the discovery.
Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.
Cirqle Biomedical develops innovative contraceptives utilizing mucus engineering technology.
Ciana Therapeutics is a clinical development-stage company developing novel therapies focusing on diabetic retinopathy.
Lophora develops new rapid-acting drugs for central nervous system diseases including treatment-resistant depression.
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
RetiPharma is a Danish Biotech company
BioInnovation Institute has invested in 141 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Medical, Biotechnology, Health Care, Therapeutics, Medical Device. The firm invests across 17 different industry categories.
Among tracked funding rounds, Synklino received $32.0M in a Series A round. BioInnovation Institute's total known invested capital is $314.9M.
BioInnovation Institute's average investment size is $4.0M across its portfolio of 141 companies.
Recent BioInnovation Institute portfolio additions include BioHalo, MedicQuant, MELLO, Amplify Therapeutics, Kesmalea Therapeutics. These companies were founded in 2020 or later.